Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74.8M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
62.3M
-
Shares change
-
-847K
-
Total reported value, excl. options
-
$395M
-
Value change
-
-$7.31M
-
Put/Call ratio
-
1.34
-
Number of buys
-
70
-
Number of sells
-
-58
-
Price
-
$6.34
Significant Holders of Zymeworks Inc. - Common Stock (ZYME) as of Q3 2023
161 filings reported holding ZYME - Zymeworks Inc. - Common Stock as of Q3 2023.
Zymeworks Inc. - Common Stock (ZYME) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.3M shares
of 74.8M outstanding shares and own 83.29% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (13.4M shares), BVF INC/IL (5.87M shares), Redmile Group, LLC (5.66M shares), MORGAN STANLEY (4.48M shares), BlackRock Inc. (3.62M shares), Rubric Capital Management LP (2.65M shares), CREDIT SUISSE AG/ (2.49M shares), VANGUARD GROUP INC (2.38M shares), FARALLON CAPITAL MANAGEMENT LLC (2M shares), and BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.56M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.